- Home
- BHVN
BHVN
Biohaven Ltd.
as 05-09-2025 4:00pm EST
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Upcoming Earnings Alert:
Get ready for potential market movements as Biohaven Ltd. BHVN prepares to release earnings report on 16 May 2025.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | NEW HAVEN |
| Market Cap: | 1.9B | IPO Year: | 2017 |
| Target Price: | $62.92 | AVG Volume (30 days): | 2.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -9.28 | EPS Growth: | N/A |
| 52 Week Low/High: | $15.79 - $55.70 | Next Earning Date: | 05-16-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 65.26% |
Stock Insider Trading Activity of Biohaven Ltd. (BHVN)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| CHILDS JOHN W | BHVN | Director | Mar 4 '25 | Buy | $30.64 | 32,700 | $996,238.47 | 2,320,571 |
Latest Biohaven Ltd. News
BHVN Breaking Stock News: Dive into BHVN Ticker-Specific Updates for Smart Investing
Insider Monkey
12 hours ago
Biohaven Ltd. (BHVN): Among Stocks That Will Bounce Back According To Analysts
Motley Fool
11 days ago
Why BioHaven Stock Is Soaring Today
PR Newswire
12 days ago
Biohaven Announces Investment up to $600 Million by Oberland Capital
TipRanks
13 days ago
Biohaven share price undervaluing pipeline potential, says RBC Capital
Motley Fool
14 days ago
Why Biohaven Stock Plummeted by More Than 15% Today
Insider Monkey
16 days ago
Jim Cramer Says Biohaven (BHVN) Is “Too Cheap” and He’s a Buyer at $21
Insider Monkey
16 days ago
Is Biohaven Ltd. (BHVN) Among the Best Guru Stocks to Buy According to Wall Street Analysts?
PR Newswire
a month ago
Biohaven Presents Data Across Innovative Neuroscience Portfolio at the 2025 American Academy of Neurology (AAN) Annual Meeting
Compare BHVN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BHVN Biohaven Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.